Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.94 USD
Change Today +0.10 / 1.71%
Volume 1.1M
ARRY On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David L. Snitman Ph.D.

AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 3 different industries.

See Board Relationships
63$960,965
As of Fiscal Year 2014

Background*

Mr. David L. Snitman, Ph.D. is the Co-founder of Array Biopharma Inc., and served as its Executive Vice President of Business Development until June 30, 2015. Mr. Snitman served as the Chief Operating Officer of Array Biopharma Inc. until March 2015 and served as its Vice President of Business Development since May 1998. Dr. Snitman held various positions with Amgen Inc., since December 1981, including an Associate Director of New Products and Technology and a Manager ...

Read Full Background

Corporate Headquarters*

3200 Walnut Street
Boulder, Colorado 80301

United States

Phone: 303-381-6600
Fax: 303-449-5376

Board Members Memberships*

2006-Present
Director

Education*

Post-Doctoral Training
Massachusetts Institute of Technology
BS
Northeastern University
PhD
University of Colorado–Boulder

Other Affiliations*

Annual Compensation*

Salary$388,625
Total Annual Compensation$388,625

Stock Options*

All Other Compensation$32,412
Exercised Options6,206
Exercised Options Value$49,548
Exercisable Options511,783
Exercisable Options Value$350,575
Unexercisable Options260,000
Unexercisable Options Value$80,325
Total Value of Options$480,448
Total Number of Options777,989

Total Compensation*

Total Annual Cash Compensation$597,136
Total Short Term Compensation$388,625
Other Long Term Compensation$32,412
Total Calculated Compensation$960,965
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARRY:US $5.94 USD +0.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer, President and Principal Financial Officer
Arena Pharmaceuticals, Inc.
$746.8K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$755.2K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$555.7K
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
€459.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARRAY BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.